For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Sipuleucel-T With DNA Vaccine | Patients receive sipuleucel-T as patients in arm I and pTVG-HP plasmid DNA vaccine ID on weeks 6, 8, 10, and 12, and then at 6 and 9 months. sipuleucel-T: Given IV DNA Vaccine: Given ID | 8 | None | 2 | 9 | 9 | 9 | View |
| Sipuleucel-T | Patients receive sipuleucel-T IV on weeks 0, 2, and 4. sipuleucel-T: Given IV | 5 | None | 1 | 9 | 9 | 9 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | NCI CTCAE v3 | View |
| Surgical and medical procedures - Other, specify | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | NCI CTCAE v3 | View |
| Hematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI CTCAE v3 | View |
| Urinary tract obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3 | View |
| Fall | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | NCI CTCAE v3 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE v3 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE v3 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Bone pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Arthritis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Flank pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Generalized muscle weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Neck pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3 | View |
| Heahache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3 | View |
| Presyncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3 | View |
| Vasovagal reaction | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3 | View |
| Urinary tract obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3 | View |
| Pelvic pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | NCI CTCAE v3 | View |
| Testicular pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | NCI CTCAE v3 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3 | View |
| Postnasal drip | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3 | View |
| Hoarseness | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3 | View |
| Skin and subcutaneous tissue disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE v3 | View |
| Surgical and medical procedures - Other, specify | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | NCI CTCAE v3 | View |
| Hematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI CTCAE v3 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI CTCAE v3 | View |
| Hot flashes | SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI CTCAE v3 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE v3 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3 | View |
| Abdominal Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3 | View |
| Gastrointestinal disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3 | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3 | View |
| Tooth infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3 | View |
| Fall | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | NCI CTCAE v3 | View |
| Fracture | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | NCI CTCAE v3 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3 | View |
| Alkaline phosphatase increased | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE v3 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |
| Non-cardiac chest pain | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |
| Injection site reaction | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |
| Localized edema | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |
| Malaise | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3 | View |